Literature DB >> 10568863

Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache.

M Ashina1, L Bendtsen, R Jensen, R Ekman, J Olesen.   

Abstract

Animal and human studies have shown that substance P (SP), neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP) are involved in the pathophysiology of acute and chronic pain conditions. The primary aim of the present study was to compare plasma levels of SP, NPY and VIP in external jugular vein between patients with chronic tension-type headache and healthy controls. The secondary aim was to examine plasma levels of these neuropeptides in relation to headache state. In addition, we wanted to study the relation between cranial circulation (jugular vein) and peripheral circulation (antecubital vein). Blood from the external jugular and antecubital vein was drawn from 20 patients with chronic tension-type headache and 20 healthy controls. Plasma SP in patients, 2.0 (1.4-2.2) pmol/l, did not differ significantly from plasma SP in controls, 1.7 (1.1-2.1) pmol/l, (P=0.44). No significant differences were found between SP levels on days with headache, 1.5 (0.3-1.7) pmol/l, and SP levels on days without headache, 1.7 (1.1-1. 9) pmol/l, (P=0.06). Plasma NPY in patients, 118+/-3 pmol/l, did not differ significantly from plasma NPY in controls, 113+/-5 pmol/l, (P=0.40). There was no difference between NPY levels on days with headache, 120+/-3 pmol/l, and on days without headache, 118+/-3 pmol/l, (P=0.73). VIP levels in patients, 6 (4-7) pmol/l, did not differ significantly from VIP levels in controls, 5 (5-7) pmol/l, (P=0.50). No significant differences were found between VIP levels measured on days with headache, 5 (4-6) pmol/l, and VIP levels measured on days without headache, 6 (4-7) pmol/l, (P=0.81). Plasma levels of SP, NPY and VIP did not significantly differ between the peripheral and the cranial circulation neither in patients nor in controls (0.05). In summary, the present study indicates that plasma levels of SP, NPY and VIP are normal in chronic tension-type headache patients and largely unrelated to headache state.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568863     DOI: 10.1016/S0304-3959(99)00159-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  4 in total

Review 1.  Tension-type headache.

Authors:  Sait Ashina; Dimos D Mitsikostas; Mi Ji Lee; Nooshin Yamani; Shuu-Jiun Wang; Roberta Messina; Håkan Ashina; Dawn C Buse; Patricia Pozo-Rosich; Rigmor H Jensen; Hans-Christoph Diener; Richard B Lipton
Journal:  Nat Rev Dis Primers       Date:  2021-03-25       Impact factor: 52.329

Review 2.  Central mechanisms in tension-type headaches.

Authors:  M Vandenheede; Jean Schoenen
Journal:  Curr Pain Headache Rep       Date:  2002-10

Review 3.  Pathophysiology of tension-type headache.

Authors:  Sait Ashina; Lars Bendtsen; Messoud Ashina
Journal:  Curr Pain Headache Rep       Date:  2005-12

4.  Salivary beta-endorphin and substance P are not biomarkers of neuropathic chronic pain propensity.

Authors:  Thomas F Kallman; Bijar Ghafouri; Emmanuel Bäckryd
Journal:  Heliyon       Date:  2018-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.